1. Home
  2. RXST vs ANGO Comparison

RXST vs ANGO Comparison

Compare RXST & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • ANGO
  • Stock Information
  • Founded
  • RXST 1997
  • ANGO 1988
  • Country
  • RXST United States
  • ANGO United States
  • Employees
  • RXST N/A
  • ANGO N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ANGO Medical/Dental Instruments
  • Sector
  • RXST Health Care
  • ANGO Health Care
  • Exchange
  • RXST Nasdaq
  • ANGO Nasdaq
  • Market Cap
  • RXST 365.8M
  • ANGO 400.8M
  • IPO Year
  • RXST 2021
  • ANGO 2004
  • Fundamental
  • Price
  • RXST $9.31
  • ANGO $10.65
  • Analyst Decision
  • RXST Hold
  • ANGO Strong Buy
  • Analyst Count
  • RXST 11
  • ANGO 3
  • Target Price
  • RXST $11.80
  • ANGO $19.00
  • AVG Volume (30 Days)
  • RXST 1.1M
  • ANGO 367.7K
  • Earning Date
  • RXST 11-06-2025
  • ANGO 10-02-2025
  • Dividend Yield
  • RXST N/A
  • ANGO N/A
  • EPS Growth
  • RXST N/A
  • ANGO N/A
  • EPS
  • RXST N/A
  • ANGO N/A
  • Revenue
  • RXST $147,059,000.00
  • ANGO $292,498,000.00
  • Revenue This Year
  • RXST N/A
  • ANGO $7.13
  • Revenue Next Year
  • RXST $6.71
  • ANGO $6.28
  • P/E Ratio
  • RXST N/A
  • ANGO N/A
  • Revenue Growth
  • RXST 27.68
  • ANGO N/A
  • 52 Week Low
  • RXST $6.32
  • ANGO $5.83
  • 52 Week High
  • RXST $57.53
  • ANGO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • RXST 54.22
  • ANGO 65.97
  • Support Level
  • RXST $8.29
  • ANGO $10.57
  • Resistance Level
  • RXST $10.25
  • ANGO $11.04
  • Average True Range (ATR)
  • RXST 0.53
  • ANGO 0.32
  • MACD
  • RXST 0.12
  • ANGO 0.07
  • Stochastic Oscillator
  • RXST 52.04
  • ANGO 72.35

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: